Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) EBT Margin (2016 - 2025)

CorMedix has reported EBT Margin over the past 12 years, most recently at 43.89% for Q4 2025.

  • Quarterly results put EBT Margin at 43.89% for Q4 2025, down 6034.0% from a year ago — trailing twelve months through Dec 2025 was 48.13% (up 4872.0% YoY), and the annual figure for FY2025 was 48.13%, up 4872.0%.
  • EBT Margin reached 43.89% in Q4 2025 per CRMD's latest filing, down from 50.42% in the prior quarter.
  • Across five years, EBT Margin topped out at 104.23% in Q4 2024 and bottomed at 100538.67% in Q3 2022.
  • Median EBT Margin over the past 4 years was 8171.25% (2021), compared with a mean of 25099.03%.
  • Peak annual rise in EBT Margin hit 3328633bps in 2022, while the deepest fall reached -8381393bps in 2022.
  • Over 4 years, EBT Margin stood at 13814.54% in 2021, then crashed by -100bps to 27637.7% in 2022, then skyrocketed by 100bps to 104.23% in 2024, then plummeted by -58bps to 43.89% in 2025.
  • Business Quant data shows EBT Margin for CRMD at 43.89% in Q4 2025, 50.42% in Q3 2025, and 51.21% in Q2 2025.